- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02430935
A Study of the Effectiveness of Cognitive Adaptation Training in Early Intervention for Psychosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The proposed project will expand knowledge of the role of compensatory and restorative cognitive interventions for early intervention population individuals with schizophrenia. The investigators will conduct a two arm randomized trial comparing the impacts of CAT and Action Based Cognitive Remediation (ABCR) for individuals with schizophrenia who are under the age of 30. The model would mirror the investigators' preliminary work at CAMH (Kidd et al., 2014) in which there will be 4 months of specialist-delivered treatment followed by 5 months of maintenance by case managers with pre, 4 month, and 9 month evaluations conducted. This study will be among the most rigorous examinations of such interventions to date, would be among the first to examine integrative approaches, and would make a substantial contribution to the early intervention literature.
The questions for the purposes of this project are:
Is CAT effective among individuals with schizophrenia under the age of 30?
and
- Does integrating cognitive remediation with CAT enhance outcomes as compared with CAT alone?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada
- Centre for Addiction and Mental Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participants must be CAMH clients, have an assigned caseworker, be between the ages of 16-34 and have a psychosis such as schizophrenia or schizoaffective disorder.
Exclusion Criteria:
- not currently experiencing high level of paranoia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Adaptation Training
Cognitive Adaptation Training (CAT) is a standardized approach to the use of environmental supports for improving multiple domains of adaptive functioning including adherence to medication, grooming, and activities of daily living in patients with schizophrenia.
|
Cognitive Adaptation Training (CAT) is a manual-driven standardized approach that uses environmental supports to improve multiple domains of adaptive functioning including adherence to medication, grooming, and activities of daily living in patients with schizophrenia.
Interventions for each functional deficit are based on two dimensions 1) level of impairment in executive functions (determined by neurocognitive tests) and 2) whether the overt behavior of the individual is characterized more by apathy (poverty of speech/movement/inability to initiate and follow through on behavioral sequences), disinhibition (distractibility/behavior which is highly cue-driven) or a combination of these styles (based on the Frontal Lobe Personality Scale (FLOPS).
|
Active Comparator: Action Based Cognitive Remediation
ABCR is applied in once weekly 2 hour sessions in small groups (6-8 per group).
In these group sessions, simulated bridging activities are done immediately following computerized cognitive activation to increase the chance that participants retain the strategies just developed in a real life environment.
|
ABCR is applied in once weekly 2 hour sessions in small groups (6-8 per group).
In these group sessions, simulated bridging activities are done immediately following computerized cognitive activation to increase the chance that participants retain the strategies just developed in a real life environment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Adaptive Functioning (SOFAS)
Time Frame: Change from baseline to 4 months and 9 months
|
A global level of social and occupational functioning will be obtained using the Social and Occupational Functioning Scale from the DSM-IV (American Psychiatric Association, 2000).
The SOFAS rates global functioning on a scale from 0 to 100.
The rating does not take into account level of symptomatology.
|
Change from baseline to 4 months and 9 months
|
Change in Adaptive Functioning (SFS)
Time Frame: Change from baseline to 4 months and 9 months
|
The Social Functioning Scale (SFS; Birchwood et al., 1990) will be administered.
This is a self-report measure that details the frequency and intensity with which the person engages in functional activities.
A total score and domain scores for social withdrawal, relationships, social activity, recreational activity, independence (competence), independence (performance) and employment are generated.
|
Change from baseline to 4 months and 9 months
|
change in Adaptive Functioning (MCAS)
Time Frame: Change from baseline to 4 months and 9 months
|
Both client and clinician versions of 17-item The Multnomah Community Ability Scale (MCAS, Barker et al., 1994) will be used to assess functionality.
|
Change from baseline to 4 months and 9 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medication Adherence
Time Frame: Throughout the 9 months of participation.
|
Medication adherence will be determined through regular pill counts of currently prescribed psychiatric medications and pharmacy records.
|
Throughout the 9 months of participation.
|
Hospitalization
Time Frame: Throughout the 9 months of participation.
|
Hospitalization will be tracked by (i) monitoring of electronic records through the central CAMH database and (ii) the reports of the primary Case Manager.
Both frequency and duration of inpatient stays will be documented as will the frequency of emergency room visits.
|
Throughout the 9 months of participation.
|
Change in Goal Attainment (GAS)
Time Frame: Change from baseline to 4 months and 9 months
|
Goal Attainment Scaling (GAS) will be employed as a sensitive measure of progress on individually defined goals that has demonstrated good reliability and validity with severe mental illness populations (Hurn et al., 2006).
Goal attainment scaling involves the setting of 3-5 goals, each operationalized on a 5-point scale.
Goals are individualized to the client and assessment of progress are determined through consensus of the clinician and case manager.
|
Change from baseline to 4 months and 9 months
|
Change in Caregiver Burden (IEQ)
Time Frame: Change from baseline to 4 months and 9 months
|
Caregiver burden will be measured for the family member involved in implementing CAT using the 31-item Involvement Evaluation Questionnaire (IEQ; Van Wijngaarden et al., 2000).
This questionnaire, which has been validated for caregivers of individuals with schizophrenia, covers a broad domain of caregiving consequences and refers to burden experienced within the past 4 weeks.
|
Change from baseline to 4 months and 9 months
|
Change in Cognition (WRAT-III)
Time Frame: Change from baseline to 4 months and 9 months
|
The Wide Range Achievement Test (WRAT-III) reading subtest (Wilkinson, 1993) will be used to evaluate pre-morbid educational attainment.
|
Change from baseline to 4 months and 9 months
|
Change in Cognition (Trail Making test part A)
Time Frame: Change from baseline to 4 months and 9 months
|
The Trail Making test part A (Radford et al., 1978), a test involving using lines to connect numbers, will be used to assess scanning ability and psychomotor speed.
|
Change from baseline to 4 months and 9 months
|
Change in Cognition (Digit Span Subtest of the Weschler Adult Intelligence Scale - III )
Time Frame: Change from baseline to 4 months and 9 months
|
Short term memory will be evaluated with the digit span subtest of the Weschler Adult Intelligence Scale - III (The Psychological Corporation, 1997).
|
Change from baseline to 4 months and 9 months
|
Change in Cognition (CVLT)
Time Frame: Change from baseline to 4 months and 9 months
|
Verbal learning and memory will be assessed with the California Verbal Learning Test (CVLT -Delis et al., 1987).
The CVLT involves the repeated presentation of a word list that determines acquisition ability and retention.
|
Change from baseline to 4 months and 9 months
|
Change in Cognition (Trail Making Test, Part B, and the Wisconsin Card Sorting Test)
Time Frame: Change from baseline to 4 months and 9 months
|
Executive functioning will be assessed with the Trail Making Test, Part B, and the Wisconsin Card Sorting Test (WCST - Berg, 1948).
|
Change from baseline to 4 months and 9 months
|
Change in Positive symptoms (BPRS-E)
Time Frame: Change from baseline to 4 months and 9 months
|
Positive symptoms will be assessed using the expanded version of the Brief Psychiatric Rating Scale (BPRS-E; Ventura et al., 1993).
The BPRS-E is a 24-item scale assessing multiple domains of psychopathology on a series of 7-point scales (1-7).
A positive symptom factor score is composed of items assessing hallucinations, unusual thought content, conceptual disorganization and suspiciousness.
|
Change from baseline to 4 months and 9 months
|
Change in Negative symptoms (NSA)
Time Frame: Change from baseline to 4 months and 9 months
|
Negative symptoms will be assessed using the Negative Symptom Assessment (NSA; Alphs et al., 1989).
The NSA is a 26-item instrument examining negative symptomatology on a series of 7-point scales (0-6).
A total negative symptom score is calculated by adding together the scores from the NSA subscales, communication, emotion, motivation, social functioning, and cognition.
|
Change from baseline to 4 months and 9 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sean Kidd, Clinician Scientist
Publications and helpful links
General Publications
- BERG EA. A simple objective technique for measuring flexibility in thinking. J Gen Psychol. 1948 Jul;39:15-22. doi: 10.1080/00221309.1948.9918159. No abstract available.
- Delis, D., Kramer, J., Kaplan. E., & Ober, B. (1987). California Verbal Learning and Memory Test (Manual). San Antonio, TX: Psychological Corporation.
- Kelland DZ, Lewis RF. The Digit Vigilance Test: reliability, validity, and sensitivity to diazepam. Arch Clin Neuropsychol. 1996;11(4):339-44.
- Radford LM, Chaney EF, O'Leary MR, O'Leary DE. Screening for cognitive impairment among inpatients. J Clin Psychiatry. 1978 Sep;39(9):712-5.
- The Psychological Corporation. (1997). WAIS-III administration and scoring manual. San Antonio, TX: Psychological Corporation.
- Wilkinson ,G. (1993). Wide Range Achievement Test 3 (Manual). Wilmington, DE: Wide Range Inc.
- Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry. 1990 Dec;157:853-9. doi: 10.1192/bjp.157.6.853.
- Alphs LD, Summerfelt A, Lann H, Muller RJ. The negative symptom assessment: a new instrument to assess negative symptoms of schizophrenia. Psychopharmacol Bull. 1989;25(2):159-63. No abstract available.
- Draper ML, Stutes DS, Maples NJ, Velligan DI. Cognitive adaptation training for outpatients with schizophrenia. J Clin Psychol. 2009 Aug;65(8):842-53. doi: 10.1002/jclp.20612.
- Kidd SA, Herman Y, Barbic S, Ganguli R, George TP, Hassan S, McKenzie K, Maples N, Velligan D. Testing a modification of cognitive adaptation training: streamlining the model for broader implementation. Schizophr Res. 2014 Jun;156(1):46-50. doi: 10.1016/j.schres.2014.03.026. Epub 2014 Apr 29.
- Kidd SA, Kaur J, Virdee G, George TP, McKenzie K, Herman Y. Cognitive remediation for individuals with psychosis in a supported education setting: a randomized controlled trial. Schizophr Res. 2014 Aug;157(1-3):90-8. doi: 10.1016/j.schres.2014.05.007. Epub 2014 Jun 2.
- Ventura J, Green MF, Shaner A, Liberman RP: Training and quality assurance with the brief psychiatric rating scale: The drift busters. International Journal of Methods in Psychiatric Research 1993; 3:221-24
- Diagnostic and statistical manual of mental disorders (4th ed.). American Psychiatric Association, Washington, DC
- Barker S, Barron N, McFarland BH, Bigelow DA. A community ability scale for chronically mentally ill consumers: Part I. Reliability and validity. Community Ment Health J. 1994 Aug;30(4):363-83. doi: 10.1007/BF02207489.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 03/24/2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosis
-
Icahn School of Medicine at Mount SinaiNational Institute of Mental Health (NIMH)Enrolling by invitationFirst Episode Psychosis (FEP) | Clinical High Risk for Psychosis (CHR)United States
-
University of UdineNational Research Council (CNR), Institute of Biomolecular Chemistry (ICB)...RecruitingClinical High Risk for Psychosis | Ultra High Risk for Psychosis | Attenuated Psychotic SymptomsItaly
-
University of New MexicoNational Institute of Mental Health (NIMH)CompletedPsychosis | Clinical High Risk for Psychosis | First Episode PsychosisUnited States
-
Shanghai Jiao Tong University School of MedicineGuangzhou Psychiatric Hospital; Suzhou Psychiatric Hospital; Tianjin Anding Hospital and other collaboratorsRecruitingSchizophrenia; Psychosis | Clinical High Risk | First Episode PsychosisChina
-
Chulalongkorn UniversityNational Research Council of Thailand; Thanyarak InstituteCompletedMethamphetamine-induced PsychosisThailand
-
University of California, San DiegoCenter for Medicinal Cannabis ResearchRecruitingEarly PsychosisUnited States
-
Yale UniversityCompleted
-
University of TorontoUniversity of British Columbia; Centre for Addiction and Mental Health; Queen... and other collaboratorsNot yet recruitingPsychotic Disorders | Schizophrenia | Psychosis | Schizophrenia; Psychosis
-
Northwell HealthNational Institute of Mental Health (NIMH)RecruitingFirst Episode PsychosisUnited States
-
State reference center for psychosocial careUniversity of ValenciaCompleted
Clinical Trials on Cognitive Adaptation Training
-
The University of Texas Health Science Center at...National Institute of Mental Health (NIMH)Completed
-
The University of Texas Health Science Center at...National Institute of Mental Health (NIMH)CompletedSchizophrenia | Bipolar Disorder | Depressive Disorder, Major | Schizo Affective DisorderUnited States
-
University of Southern DenmarkCompletedSchizophreniaDenmark
-
Centre for Addiction and Mental HealthCompletedSchizophreniaCanada
-
Centre for Addiction and Mental HealthCompleted
-
The University of Texas Health Science Center at...National Institute of Mental Health (NIMH); Vanguard Research GroupActive, not recruitingSchizophrenia | Schizoaffective DisorderUnited States
-
University Hospital, MontpellierUnknown
-
The University of Texas Health Science Center at...CompletedSchizophrenia | Schizoaffective Disorder
-
Massachusetts Eye and Ear InfirmaryOregon Health and Science University; National Institute on Deafness and Other... and other collaboratorsEnrolling by invitationMigraine | Dizziness | Motion Sickness | Vestibular Migraine | Vestibular Schwannoma | Vestibular DisorderUnited States
-
Sunnyview Rehabilitation HospitalCompleted